Anna Goryachova Mezzo-soprano

Biography

Anna Goryachova studied at the Rimsky-Korsakov St Petersburg State Conservatory, then at the Accademia di Santa Cecilia in Rome. She won the 2nd Prize and the Special Prize at the Galina Vishnevskaya International Opera Singers’ Competition in Moscow, and the Vera and Volker Doppelfeld Foundation Prize in Germany. 

In 2009 she sang the title-role in Carmen at the Classic Open air Festival in Berlin and took part in the creation of Philip Glass's opera Witches of Venice in Rome. In 2011, she sang Melibea in Il viaggio a Reims in Antwerp and Ghent. The following year, she made her role debut as Alcina (Haydn's Orlando Paladino) at the Théâtre du Châtelet and sang Carmen in Antwerp. She was invited by the Rossini Festival in Pesaro to sing Edoardo in Matilde di Shabran

Since season 2012/13, she has joined the Opernhaus Zürich company, where she performed, among others, in Salome (the Page of Herodias), La Scala di seta (Lucilla), Three Sisters by Peter Eötvös (Masha), Rinaldo, Don Giovanni (Zerlina), Die Meistersinger von Nürnberg (Magdalena). In 2013, she portrayed Isabella in L'italiana in Algeri at the Rossini Festival in Pesaro. 

She made her Paris Opera debut in 2014 in Alcina (Ruggiero). In 2015, she made her Amsterdam debut in Il viaggio a Reims (Melibea) and also performed in Florence in Così fan tutte (Dorabella). She went on with Rosina in The Barber of Seville in Saint Petersburg. 

Recent seasons saw her performing the title-role in La Cenerentola in Oslo and at the Vienna Staatsoper, in Carmen at Teatro Real, Madrid, the Arena di Verona and the Vienna Staatsoper, in Tancrède in Beaune, and the roles of Dorabella in Zurich, Dulcinea in Don Quixote in Bregenz, Dido in Dido and Æneas and Rosina at the Bolshoi Theatre in Moscow, Angelina in La Cenerentola and Sesto in La clemenza di Tito at the Geneva's Grand Théâtre, Olga in Eugene Onegin at the Vienna Staatsoper, Isabella in L’italianna in Algeri in Beaune et at the Uzès Festival.

Immerse in the Paris Opera universe

Follow us

Back to top